Skip to main content
. 2010 Dec;161(8):1857–1867. doi: 10.1111/j.1476-5381.2010.01007.x

Figure 3.

Figure 3

Assessement of predictive performance of final population models for both treatments: pralidoxime and AIBC. Plots of residual versus predicted concentrations for pralidoxime (A) and AIBC (B), and residual versus time for pralidoxime (C) and AIBC (D).